• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Sabra Health Care REIT, Inc. Completes the Sale of Nine Facilities Leased to Genesis; Sells a Facility Leased to Signature HealthCARE

Share:

July 15, 2018

Sabra Health Care REIT, Inc. announced today that on June 29, 2018, it completed the previously announced sale of nine facilities (seven skilled nursing facilities, one senior housing community and one continuing care retirement community) leased to Genesis Healthcare, Inc. (“Genesis”) for $81.4 million. Under the terms of Sabra’s memoranda of understanding with Genesis, Genesis’s annual rent obligations to Sabra were reduced by $7.4 million as a result of the sale of these facilities.

Also, on July 2, 2018, Sabra sold a skilled nursing facility leased to Signature HealthCARE (“Signature”) for $7.0 million. Annual rent obligations from Signature were reduced by $0.6 million as a result of the sale of this facility, consistent with previous expectations.

Sabra expects to use the proceeds from these sales to repay borrowings under its revolving credit facility.

The sales of the nine Genesis facilities and the Signature facility were contemplated in the Company’s recently updated 2018 earnings guidance.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Date: July 16, 2018

Source: CNBC

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Elysium Health™ Announces $40 Million Series C Financing Led by GISEV Family OfficeElysium Health™ Announces $40 Million Series C Financing Led by GISEV Family Office
  • Bausch Health Confirms ‘Stalking Horse’ Agreement to Acquire Substantially All Assets of Synergy PharmaceuticalsBausch Health Confirms ‘Stalking Horse’ Agreement to Acquire Substantially All Assets of Synergy Pharmaceuticals
  • Moderna, IBM Partner on COVID-19 Vaccine Supply Chain & Distribution Data SharingModerna, IBM Partner on COVID-19 Vaccine Supply Chain & Distribution Data Sharing
  • Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in the U.S.Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in the U.S.
  • TytoCare Scores $49M to Explore Further Use Cases of Its AI TechnologyTytoCare Scores $49M to Explore Further Use Cases of Its AI Technology
  • Synteract Acquires Pediatric CRO KinderPharm to Further Strengthen its Pediatric Center of DevelopmentSynteract Acquires Pediatric CRO KinderPharm to Further Strengthen its Pediatric Center of Development
  • Compass Diversified to sell Advanced Circuits for $220M enterprise valueCompass Diversified to sell Advanced Circuits for $220M enterprise value
  • Fast-Growing Health Recovery Solutions Raises $10M For Remote Patient MonitoringFast-Growing Health Recovery Solutions Raises $10M For Remote Patient Monitoring

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications